---
title: "Top 10 港股跌幅（2月26日）"
description: "中升控股 (00881) 跌 10.76%，成交额 3.2 亿港元，年内累计跌 10.8%。 鈞達股份 (02865) 跌 9.32%，成交额 4.5 亿港元，年内累计涨 51.2%。 中創新航 (03931) 跌 9.26%，成交额 1.8 亿港元，年内累计跌 0.1%。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/277006250.md"
published_at: "2026-02-26T08:30:44.000Z"
---

# Top 10 港股跌幅（2月26日）

> 中升控股 (00881) 跌 10.76%，成交额 3.2 亿港元，年内累计跌 10.8%。 鈞達股份 (02865) 跌 9.32%，成交额 4.5 亿港元，年内累计涨 51.2%。 中創新航 (03931) 跌 9.26%，成交额 1.8 亿港元，年内累计跌 0.1%。

恆生指數跌 1.44%，年内累計涨 2.9%；恆生科技指數跌 2.87%，年内累計跌 7.4%。

中升控股 (00881) 跌 10.76%，成交额 3.2 亿港元，年内累计跌 10.8%。

鈞達股份 (02865) 跌 9.32%，成交额 4.5 亿港元，年内累计涨 51.2%。

中創新航 (03931) 跌 9.26%，成交额 1.8 亿港元，年内累计跌 0.1%。

### Related Stocks

- [00881.HK - 中升控股](https://longbridge.com/zh-HK/quote/00881.HK.md)
- [02865.HK - 鈞達股份](https://longbridge.com/zh-HK/quote/02865.HK.md)
- [03931.HK - 中創新航](https://longbridge.com/zh-HK/quote/03931.HK.md)
- [06160.HK - 百濟神州](https://longbridge.com/zh-HK/quote/06160.HK.md)
- [00400.HK - 硬蛋創新](https://longbridge.com/zh-HK/quote/00400.HK.md)
- [02268.HK - 藥明合聯](https://longbridge.com/zh-HK/quote/02268.HK.md)
- [02509.HK - 荃信生物-B](https://longbridge.com/zh-HK/quote/02509.HK.md)
- [02659.HK - 寶濟藥業-B](https://longbridge.com/zh-HK/quote/02659.HK.md)
- [02096.HK - 先聲藥業](https://longbridge.com/zh-HK/quote/02096.HK.md)
- [02269.HK - 藥明生物](https://longbridge.com/zh-HK/quote/02269.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BeOne Medicines posts 2025 results and issues cautious 2026 outlook | BeOne Medicines Ltd, a biopharmaceutical company based in Switzerland and listed in Hong Kong, has released its unaudite | [Link](https://longbridge.com/zh-HK/news/277035413.md) |
| CALB Group's Profit Jumps in Q1-Q3 | CALB Group's Profit Jumps in Q1-Q3 | [Link](https://longbridge.com/zh-HK/news/263767057.md) |
| Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows | Morgan Stanley's long position in Wuxi Biologics (Cayman) decreases to 2.11% on Jan 20 from 5.58%, HKEX shows | [Link](https://longbridge.com/zh-HK/news/273496397.md) |
| Zhongsheng Group Files Director List with HKEX | Zhongsheng Group Holdings Limited has submitted an updated director list to the Hong Kong Stock Exchange. The Board incl | [Link](https://longbridge.com/zh-HK/news/273661580.md) |
| CALB Group Acquires 8.3% Stake in Wuhan Company | CALB Group Co., Ltd. acquired an 8.3155% stake in Wuhan Company through a public tender, completed on December 24, 2025. | [Link](https://longbridge.com/zh-HK/news/270729477.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。